Company to Invest Approximately $2 Million, Increase Workforce
CoreRx, Inc. is pleased to announce they are now occupying their new 35,000 square foot facility in Clearwater, FL. This distinct facility will enable CoreRx’s scientific staff to custom formulate, analyze and manufacture the highest quality pharmaceutical products for their client-partners.
Continuing to exceed industry expectations, CoreRx, a Tampa-based pharmaceutical development company, added two new critical roles to their growing organization; Director of Commercial Manufacturing, and a Manager of Marketing & Strategic Development.
CoreRx, Inc., a Tampa-based pharmaceutical development company, which has already begun a major expansion of its new headquarters at 14205 Myerlake Circle, today announces the addition of SuiteView to its service offerings.
CoreRx has appointed William Beck as Director, Business Development, covering the Northeast. Mr. Beck will be responsible for all business development activities in support of the company’s strategic growth and development plans for this region.
CoreRx, a leader in early drug contract development, has expanded manufacturing capabilities to include the OYSTAR Manesty FLEXITAB, A fully automated, single station tablet press with a multi-layer tablet function, giving it the unique capacity to produce three-layer tablets using a minimal amount of material. Its variable punch displacement and dwell time can be set to simulate compression on any rotary press using compression forces up to100kN.